Autoimmune Disease Diagnostics Market Hit 5,054.12 Million USD by the End of 2026

New York, NY -- (SBWire) -- 10/08/2018 --The global Autoimmune Disease Diagnostics Market at USD 3520.17 Million in 2017 which is anticipated to reach USD 5054.12 Million by 2026 growing at a CAGR of 4.05% according to a new research report.

The immune system of human body identifies some invaders such as viruses, bacteria, and other exterior foreign substances and attacks those foreign elements to defend the body. Nevertheless, in some cases, the body immune system attacks the healthy cells of the body by considering those cells as foreign materials. Such kind of condition is termed as an autoimmune disease. The autoimmune disease causes atypical tissue growth and deviations in function of the organ. The principal cause of autoimmune development may be the person's genes with environmental exposure. Currently, there are approximately more than 80 types of autoimmune diseases. Some of the acutest autoimmune diseases are inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus, and type 1 diabetes. The accurate therapeutic therapy for autoimmune diseases is not accessible yet but only relieving managements are available for this ailments. Nonetheless, diagnosis of the autoimmune diseases can be done by the tests involving complete blood counts, an antibody test, antinuclear antibody test others.

Get Free Sample Copy of this Report @ https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market/request-for-free-sample

The global autoimmune disease diagnostics market is majorly driven by the increase in the number of people suffering autoimmune diseases. For instance, according to American Autoimmune Related Disease Association (AARDA) reports of 2016, approximately 50 million people suffered autoimmune diseases in the U.S. with around 75% being women. Moreover, rising government initiatives and public consciousness are taken to devote the budget on diagnosis and care services for autoimmune diseases, are another factors which are propelling the global autoimmune disease diagnostics market. Additionally, many of the governments, as well as organizations, are investing in the research and development programs to discover proper care for autoimmune diseases treatments, this factor is expected to help to introduce the new products in the market further augmenting autoimmune disease diagnostics market during the forecast period. For instance, the introduction of novel biomarkers, which has established to be substantial to increase the diagnosis of autoimmune diseases is correspondingly one of the major factor driving the autoimmune diseases diagnostic market.

Polaris Market Research provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the global Autoimmune Disease Diagnostics Market, 2017-2026. This report comprises a detailed geographic distribution of the market across North America, Europe, APAC and South America, and MEA. North America is further segmented into U.S., Canada, and Mexico. Europe is divided into Germany, UK, Italy, France, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific.

In terms of geography, North America is estimated to dominate the global autoimmune disease diagnostics market. The dominance is majorly attributed to increasing prevalence of some of the common autoimmune diseases such as type1 diabetes and rheumatoid arthritis. The surge in funding by private and government organizations, growing regulatory scenario observed by World Health Organization (WHO), and advancement in technology are some of the other factors driving the growth of the autoimmune disease diagnostics market in North America. However, the Asia Pacific is expected to be a fast emerging region in the global autoimmune disease diagnostics market. The swift growth is attributed to the increasing incidences of the autoimmune disease, large investments in R&D and surging government support to control the autoimmune disease. the Asia Pacific is expected to dominate the market during the forecast period.

Competitive Landscape and Key Vendors

The global Autoimmune Disease Diagnostics Market is characterized by the presence of well-diversified global and local vendors. These companies are consistently launching new products to enhance their offerings in the market. With the advancement of technologies and the product inventions, companies are innovating and introducing new customized products to cater the growing needs of the customers. The leading companies investigated in the report are F. Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, EUROIMMUN AG, AESKU.Diagnostics GmbH & Co. KG,INOVA Diagnostics, Inc., Crescendo Bioscience, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., Hemagen Diagnostics, Inc.

Make an Inquiry @ https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market/inquire-before-buying

As per the analysts of Polaris Market Research, the market segmentation is as below:

Type

- Systemic autoimmune disease diagnostics

o Rheumatoid arthritis
o Ankylosing spondylitis
o Systemic lupus erythematosus (SLE)
o Others.

- Localized autoimmune disease diagnostics

o Multiple sclerosis
o Type 1 diabetes
o Hashimoto's Thyroiditis
o Idiopathic thrombocytopenic purpura

End User

- Hospitals
- Diagnostics Centers
- Research Laboratories

Complete Report with TOC Available @ https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market/

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

Contact us

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: neel@polarismarketresearch.com
Web: www.polarismarketresearch.com